nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—ABCB1—ulcerative colitis	0.274	1	CbGaD
Temsirolimus—CYP3A4—Budesonide—ulcerative colitis	0.0344	0.0748	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Hydrocortisone—ulcerative colitis	0.032	0.0695	CbGbCtD
Temsirolimus—CYP3A7—Hydrocortisone—ulcerative colitis	0.032	0.0695	CbGbCtD
Temsirolimus—CYP3A5—Sulfasalazine—ulcerative colitis	0.0299	0.0649	CbGbCtD
Temsirolimus—ABCB1—Methylprednisolone—ulcerative colitis	0.0257	0.0558	CbGbCtD
Temsirolimus—CYP3A5—Hydrocortisone—ulcerative colitis	0.024	0.0521	CbGbCtD
Temsirolimus—CYP2D6—Nicotine—ulcerative colitis	0.0236	0.0512	CbGbCtD
Temsirolimus—CYP2D6—Cholecalciferol—ulcerative colitis	0.0211	0.0459	CbGbCtD
Temsirolimus—CYP3A7—Dexamethasone—ulcerative colitis	0.0199	0.0432	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Dexamethasone—ulcerative colitis	0.0199	0.0432	CbGbCtD
Temsirolimus—ABCB1—Betamethasone—ulcerative colitis	0.0167	0.0363	CbGbCtD
Temsirolimus—ABCB1—Prednisolone—ulcerative colitis	0.0165	0.0358	CbGbCtD
Temsirolimus—ABCB1—Hydrocortisone—ulcerative colitis	0.0156	0.0339	CbGbCtD
Temsirolimus—ABCB1—Prednisone—ulcerative colitis	0.0156	0.0338	CbGbCtD
Temsirolimus—CYP3A4—Methylprednisolone—ulcerative colitis	0.0154	0.0334	CbGbCtD
Temsirolimus—CYP3A4—Nicotine—ulcerative colitis	0.015	0.0326	CbGbCtD
Temsirolimus—CYP3A5—Dexamethasone—ulcerative colitis	0.0149	0.0324	CbGbCtD
Temsirolimus—CYP3A4—Cholecalciferol—ulcerative colitis	0.0134	0.0292	CbGbCtD
Temsirolimus—CYP3A4—Triamcinolone—ulcerative colitis	0.0117	0.0253	CbGbCtD
Temsirolimus—CYP3A4—Betamethasone—ulcerative colitis	0.01	0.0217	CbGbCtD
Temsirolimus—CYP3A4—Prednisolone—ulcerative colitis	0.00987	0.0214	CbGbCtD
Temsirolimus—ABCB1—Dexamethasone—ulcerative colitis	0.00971	0.0211	CbGbCtD
Temsirolimus—CYP3A4—Hydrocortisone—ulcerative colitis	0.00936	0.0203	CbGbCtD
Temsirolimus—CYP3A4—Prednisone—ulcerative colitis	0.00932	0.0202	CbGbCtD
Temsirolimus—CYP2D6—Dexamethasone—ulcerative colitis	0.00915	0.0199	CbGbCtD
Temsirolimus—CYP3A4—Dexamethasone—ulcerative colitis	0.00582	0.0126	CbGbCtD
Temsirolimus—MTOR—epithelium—ulcerative colitis	0.000855	0.0924	CbGeAlD
Temsirolimus—MTOR—smooth muscle tissue—ulcerative colitis	0.000824	0.089	CbGeAlD
Temsirolimus—FKBP1A—epithelium—ulcerative colitis	0.000769	0.0831	CbGeAlD
Temsirolimus—FKBP1A—smooth muscle tissue—ulcerative colitis	0.000741	0.0801	CbGeAlD
Temsirolimus—MTOR—lymphoid tissue—ulcerative colitis	0.000658	0.0712	CbGeAlD
Temsirolimus—MTOR—digestive system—ulcerative colitis	0.00065	0.0703	CbGeAlD
Temsirolimus—FKBP1A—lymphoid tissue—ulcerative colitis	0.000592	0.064	CbGeAlD
Temsirolimus—Tacrolimus—ALB—ulcerative colitis	0.000586	0.344	CrCbGaD
Temsirolimus—FKBP1A—digestive system—ulcerative colitis	0.000585	0.0632	CbGeAlD
Temsirolimus—Sirolimus—ABCB1—ulcerative colitis	0.00056	0.328	CrCbGaD
Temsirolimus—Tacrolimus—ABCB1—ulcerative colitis	0.00056	0.328	CrCbGaD
Temsirolimus—CYP3A7—liver—ulcerative colitis	0.000539	0.0583	CbGeAlD
Temsirolimus—MTOR—liver—ulcerative colitis	0.000484	0.0524	CbGeAlD
Temsirolimus—CYP3A7-CYP3A51P—liver—ulcerative colitis	0.000458	0.0496	CbGeAlD
Temsirolimus—FKBP1A—liver—ulcerative colitis	0.000436	0.0471	CbGeAlD
Temsirolimus—CYP3A5—digestive system—ulcerative colitis	0.000255	0.0275	CbGeAlD
Temsirolimus—CYP3A4—digestive system—ulcerative colitis	0.000191	0.0207	CbGeAlD
Temsirolimus—CYP3A5—liver—ulcerative colitis	0.00019	0.0205	CbGeAlD
Temsirolimus—CYP2D6—digestive system—ulcerative colitis	0.000188	0.0203	CbGeAlD
Temsirolimus—ABCB1—epithelium—ulcerative colitis	0.000178	0.0192	CbGeAlD
Temsirolimus—CYP3A4—liver—ulcerative colitis	0.000142	0.0154	CbGeAlD
Temsirolimus—CYP2D6—liver—ulcerative colitis	0.00014	0.0151	CbGeAlD
Temsirolimus—Eye disorder—Methylprednisolone—ulcerative colitis	0.00014	0.000754	CcSEcCtD
Temsirolimus—Mental disorder—Hydrocortisone—ulcerative colitis	0.00014	0.000753	CcSEcCtD
Temsirolimus—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000139	0.000749	CcSEcCtD
Temsirolimus—Erythema—Hydrocortisone—ulcerative colitis	0.000139	0.000748	CcSEcCtD
Temsirolimus—Malnutrition—Hydrocortisone—ulcerative colitis	0.000139	0.000748	CcSEcCtD
Temsirolimus—Neutropenia—Prednisone—ulcerative colitis	0.000139	0.000747	CcSEcCtD
Temsirolimus—Pruritus—Budesonide—ulcerative colitis	0.000138	0.000747	CcSEcCtD
Temsirolimus—Decreased appetite—Mesalazine—ulcerative colitis	0.000138	0.000746	CcSEcCtD
Temsirolimus—Body temperature increased—Azathioprine—ulcerative colitis	0.000138	0.000745	CcSEcCtD
Temsirolimus—Abdominal pain—Azathioprine—ulcerative colitis	0.000138	0.000745	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000137	0.000741	CcSEcCtD
Temsirolimus—Fatigue—Mesalazine—ulcerative colitis	0.000137	0.00074	CcSEcCtD
Temsirolimus—ABCB1—lymphoid tissue—ulcerative colitis	0.000137	0.0148	CbGeAlD
Temsirolimus—Pain—Mesalazine—ulcerative colitis	0.000136	0.000734	CcSEcCtD
Temsirolimus—Constipation—Mesalazine—ulcerative colitis	0.000136	0.000734	CcSEcCtD
Temsirolimus—Angiopathy—Methylprednisolone—ulcerative colitis	0.000136	0.000732	CcSEcCtD
Temsirolimus—ABCB1—digestive system—ulcerative colitis	0.000135	0.0146	CbGeAlD
Temsirolimus—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000135	0.000729	CcSEcCtD
Temsirolimus—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000135	0.000728	CcSEcCtD
Temsirolimus—Weight decreased—Prednisone—ulcerative colitis	0.000134	0.000723	CcSEcCtD
Temsirolimus—Diarrhoea—Budesonide—ulcerative colitis	0.000134	0.000722	CcSEcCtD
Temsirolimus—Hyperglycaemia—Prednisone—ulcerative colitis	0.000134	0.00072	CcSEcCtD
Temsirolimus—Depression—Prednisone—ulcerative colitis	0.000132	0.00071	CcSEcCtD
Temsirolimus—Mental disorder—Methylprednisolone—ulcerative colitis	0.000131	0.000707	CcSEcCtD
Temsirolimus—Erythema—Triamcinolone—ulcerative colitis	0.000131	0.000704	CcSEcCtD
Temsirolimus—Erythema—Methylprednisolone—ulcerative colitis	0.00013	0.000703	CcSEcCtD
Temsirolimus—Malnutrition—Methylprednisolone—ulcerative colitis	0.00013	0.000703	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.00013	0.000702	CcSEcCtD
Temsirolimus—Angioedema—Prednisolone—ulcerative colitis	0.00013	0.0007	CcSEcCtD
Temsirolimus—Dizziness—Budesonide—ulcerative colitis	0.000129	0.000698	CcSEcCtD
Temsirolimus—Hypersensitivity—Azathioprine—ulcerative colitis	0.000129	0.000694	CcSEcCtD
Temsirolimus—Dysgeusia—Triamcinolone—ulcerative colitis	0.000128	0.00069	CcSEcCtD
Temsirolimus—Eye disorder—Dexamethasone—ulcerative colitis	0.000127	0.000686	CcSEcCtD
Temsirolimus—Eye disorder—Betamethasone—ulcerative colitis	0.000127	0.000686	CcSEcCtD
Temsirolimus—Angioedema—Hydrocortisone—ulcerative colitis	0.000127	0.000683	CcSEcCtD
Temsirolimus—Back pain—Triamcinolone—ulcerative colitis	0.000126	0.000681	CcSEcCtD
Temsirolimus—Abdominal pain—Mesalazine—ulcerative colitis	0.000126	0.000679	CcSEcCtD
Temsirolimus—Body temperature increased—Mesalazine—ulcerative colitis	0.000126	0.000679	CcSEcCtD
Temsirolimus—Vomiting—Budesonide—ulcerative colitis	0.000124	0.000671	CcSEcCtD
Temsirolimus—Angiopathy—Betamethasone—ulcerative colitis	0.000124	0.000666	CcSEcCtD
Temsirolimus—Angiopathy—Dexamethasone—ulcerative colitis	0.000124	0.000666	CcSEcCtD
Temsirolimus—Rash—Budesonide—ulcerative colitis	0.000123	0.000666	CcSEcCtD
Temsirolimus—Dermatitis—Budesonide—ulcerative colitis	0.000123	0.000665	CcSEcCtD
Temsirolimus—Convulsion—Prednisolone—ulcerative colitis	0.000123	0.000664	CcSEcCtD
Temsirolimus—Headache—Budesonide—ulcerative colitis	0.000123	0.000661	CcSEcCtD
Temsirolimus—Hypertension—Prednisolone—ulcerative colitis	0.000123	0.000661	CcSEcCtD
Temsirolimus—Convulsion—Hydrocortisone—ulcerative colitis	0.00012	0.000648	CcSEcCtD
Temsirolimus—Hypertension—Hydrocortisone—ulcerative colitis	0.00012	0.000646	CcSEcCtD
Temsirolimus—Diarrhoea—Azathioprine—ulcerative colitis	0.00012	0.000645	CcSEcCtD
Temsirolimus—Angioedema—Triamcinolone—ulcerative colitis	0.000119	0.000644	CcSEcCtD
Temsirolimus—Angioedema—Methylprednisolone—ulcerative colitis	0.000119	0.000642	CcSEcCtD
Temsirolimus—Erythema—Betamethasone—ulcerative colitis	0.000119	0.000639	CcSEcCtD
Temsirolimus—Erythema—Dexamethasone—ulcerative colitis	0.000119	0.000639	CcSEcCtD
Temsirolimus—Myalgia—Hydrocortisone—ulcerative colitis	0.000118	0.000637	CcSEcCtD
Temsirolimus—Anxiety—Hydrocortisone—ulcerative colitis	0.000118	0.000635	CcSEcCtD
Temsirolimus—Hypersensitivity—Mesalazine—ulcerative colitis	0.000117	0.000632	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000117	0.000632	CcSEcCtD
Temsirolimus—Connective tissue disorder—Prednisone—ulcerative colitis	0.000117	0.000628	CcSEcCtD
Temsirolimus—Nausea—Budesonide—ulcerative colitis	0.000116	0.000627	CcSEcCtD
Temsirolimus—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000116	0.000625	CcSEcCtD
Temsirolimus—Oedema—Prednisolone—ulcerative colitis	0.000116	0.000625	CcSEcCtD
Temsirolimus—Dizziness—Azathioprine—ulcerative colitis	0.000116	0.000623	CcSEcCtD
Temsirolimus—Asthenia—Mesalazine—ulcerative colitis	0.000114	0.000616	CcSEcCtD
Temsirolimus—Cough—Triamcinolone—ulcerative colitis	0.000114	0.000615	CcSEcCtD
Temsirolimus—Oedema—Hydrocortisone—ulcerative colitis	0.000113	0.00061	CcSEcCtD
Temsirolimus—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000113	0.00061	CcSEcCtD
Temsirolimus—Convulsion—Triamcinolone—ulcerative colitis	0.000113	0.00061	CcSEcCtD
Temsirolimus—Convulsion—Methylprednisolone—ulcerative colitis	0.000113	0.000609	CcSEcCtD
Temsirolimus—Hypertension—Triamcinolone—ulcerative colitis	0.000113	0.000608	CcSEcCtD
Temsirolimus—Pruritus—Mesalazine—ulcerative colitis	0.000113	0.000607	CcSEcCtD
Temsirolimus—Hypertension—Methylprednisolone—ulcerative colitis	0.000113	0.000607	CcSEcCtD
Temsirolimus—Infection—Hydrocortisone—ulcerative colitis	0.000112	0.000606	CcSEcCtD
Temsirolimus—Myalgia—Triamcinolone—ulcerative colitis	0.000111	0.0006	CcSEcCtD
Temsirolimus—Vomiting—Azathioprine—ulcerative colitis	0.000111	0.000599	CcSEcCtD
Temsirolimus—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000111	0.000599	CcSEcCtD
Temsirolimus—Arthralgia—Methylprednisolone—ulcerative colitis	0.000111	0.000598	CcSEcCtD
Temsirolimus—Myalgia—Methylprednisolone—ulcerative colitis	0.000111	0.000598	CcSEcCtD
Temsirolimus—Eye disorder—Prednisone—ulcerative colitis	0.000111	0.000597	CcSEcCtD
Temsirolimus—Anxiety—Methylprednisolone—ulcerative colitis	0.000111	0.000596	CcSEcCtD
Temsirolimus—Rash—Azathioprine—ulcerative colitis	0.00011	0.000594	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.00011	0.000594	CcSEcCtD
Temsirolimus—Dermatitis—Azathioprine—ulcerative colitis	0.00011	0.000594	CcSEcCtD
Temsirolimus—Skin disorder—Hydrocortisone—ulcerative colitis	0.00011	0.000593	CcSEcCtD
Temsirolimus—Headache—Azathioprine—ulcerative colitis	0.000109	0.00059	CcSEcCtD
Temsirolimus—Diarrhoea—Mesalazine—ulcerative colitis	0.000109	0.000587	CcSEcCtD
Temsirolimus—Angioedema—Dexamethasone—ulcerative colitis	0.000108	0.000584	CcSEcCtD
Temsirolimus—Angioedema—Betamethasone—ulcerative colitis	0.000108	0.000584	CcSEcCtD
Temsirolimus—Anorexia—Hydrocortisone—ulcerative colitis	0.000108	0.000582	CcSEcCtD
Temsirolimus—Angiopathy—Prednisone—ulcerative colitis	0.000108	0.00058	CcSEcCtD
Temsirolimus—Immune system disorder—Prednisone—ulcerative colitis	0.000107	0.000577	CcSEcCtD
Temsirolimus—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000107	0.000575	CcSEcCtD
Temsirolimus—Oedema—Triamcinolone—ulcerative colitis	0.000107	0.000575	CcSEcCtD
Temsirolimus—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000106	0.000574	CcSEcCtD
Temsirolimus—Infection—Triamcinolone—ulcerative colitis	0.000106	0.000571	CcSEcCtD
Temsirolimus—Infection—Methylprednisolone—ulcerative colitis	0.000106	0.00057	CcSEcCtD
Temsirolimus—Dizziness—Mesalazine—ulcerative colitis	0.000105	0.000568	CcSEcCtD
Temsirolimus—Insomnia—Prednisolone—ulcerative colitis	0.000105	0.000565	CcSEcCtD
Temsirolimus—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000104	0.000562	CcSEcCtD
Temsirolimus—Mental disorder—Prednisone—ulcerative colitis	0.000104	0.00056	CcSEcCtD
Temsirolimus—Nausea—Azathioprine—ulcerative colitis	0.000104	0.00056	CcSEcCtD
Temsirolimus—Skin disorder—Methylprednisolone—ulcerative colitis	0.000103	0.000557	CcSEcCtD
Temsirolimus—Malnutrition—Prednisone—ulcerative colitis	0.000103	0.000557	CcSEcCtD
Temsirolimus—Erythema—Prednisone—ulcerative colitis	0.000103	0.000557	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000103	0.000556	CcSEcCtD
Temsirolimus—Convulsion—Dexamethasone—ulcerative colitis	0.000103	0.000554	CcSEcCtD
Temsirolimus—Convulsion—Betamethasone—ulcerative colitis	0.000103	0.000554	CcSEcCtD
Temsirolimus—Insomnia—Hydrocortisone—ulcerative colitis	0.000102	0.000552	CcSEcCtD
Temsirolimus—Hypertension—Dexamethasone—ulcerative colitis	0.000102	0.000552	CcSEcCtD
Temsirolimus—Hypertension—Betamethasone—ulcerative colitis	0.000102	0.000552	CcSEcCtD
Temsirolimus—Vomiting—Mesalazine—ulcerative colitis	0.000101	0.000546	CcSEcCtD
Temsirolimus—Myalgia—Dexamethasone—ulcerative colitis	0.000101	0.000544	CcSEcCtD
Temsirolimus—Myalgia—Betamethasone—ulcerative colitis	0.000101	0.000544	CcSEcCtD
Temsirolimus—ABCB1—liver—ulcerative colitis	0.000101	0.0109	CbGeAlD
Temsirolimus—Anxiety—Dexamethasone—ulcerative colitis	0.000101	0.000542	CcSEcCtD
Temsirolimus—Anxiety—Betamethasone—ulcerative colitis	0.000101	0.000542	CcSEcCtD
Temsirolimus—Rash—Mesalazine—ulcerative colitis	0.0001	0.000541	CcSEcCtD
Temsirolimus—Dermatitis—Mesalazine—ulcerative colitis	0.0001	0.000541	CcSEcCtD
Temsirolimus—Headache—Mesalazine—ulcerative colitis	9.97e-05	0.000538	CcSEcCtD
Temsirolimus—Pain—Prednisolone—ulcerative colitis	9.91e-05	0.000535	CcSEcCtD
Temsirolimus—Decreased appetite—Hydrocortisone—ulcerative colitis	9.84e-05	0.000531	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	9.77e-05	0.000527	CcSEcCtD
Temsirolimus—Fatigue—Hydrocortisone—ulcerative colitis	9.76e-05	0.000526	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	9.71e-05	0.000524	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	9.69e-05	0.000523	CcSEcCtD
Temsirolimus—Pain—Hydrocortisone—ulcerative colitis	9.68e-05	0.000522	CcSEcCtD
Temsirolimus—Oedema—Dexamethasone—ulcerative colitis	9.67e-05	0.000522	CcSEcCtD
Temsirolimus—Anaphylactic shock—Dexamethasone—ulcerative colitis	9.67e-05	0.000522	CcSEcCtD
Temsirolimus—Anaphylactic shock—Betamethasone—ulcerative colitis	9.67e-05	0.000522	CcSEcCtD
Temsirolimus—Oedema—Betamethasone—ulcerative colitis	9.67e-05	0.000522	CcSEcCtD
Temsirolimus—Insomnia—Triamcinolone—ulcerative colitis	9.64e-05	0.00052	CcSEcCtD
Temsirolimus—Insomnia—Methylprednisolone—ulcerative colitis	9.62e-05	0.000519	CcSEcCtD
Temsirolimus—Infection—Betamethasone—ulcerative colitis	9.61e-05	0.000518	CcSEcCtD
Temsirolimus—Infection—Dexamethasone—ulcerative colitis	9.61e-05	0.000518	CcSEcCtD
Temsirolimus—Anaemia—Prednisone—ulcerative colitis	9.54e-05	0.000514	CcSEcCtD
Temsirolimus—Dyspnoea—Triamcinolone—ulcerative colitis	9.5e-05	0.000512	CcSEcCtD
Temsirolimus—Nervous system disorder—Betamethasone—ulcerative colitis	9.49e-05	0.000511	CcSEcCtD
Temsirolimus—Nervous system disorder—Dexamethasone—ulcerative colitis	9.49e-05	0.000511	CcSEcCtD
Temsirolimus—Thrombocytopenia—Dexamethasone—ulcerative colitis	9.47e-05	0.000511	CcSEcCtD
Temsirolimus—Thrombocytopenia—Betamethasone—ulcerative colitis	9.47e-05	0.000511	CcSEcCtD
Temsirolimus—Nausea—Mesalazine—ulcerative colitis	9.46e-05	0.00051	CcSEcCtD
Temsirolimus—Angioedema—Prednisone—ulcerative colitis	9.43e-05	0.000509	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	9.26e-05	0.000499	CcSEcCtD
Temsirolimus—Anorexia—Dexamethasone—ulcerative colitis	9.22e-05	0.000497	CcSEcCtD
Temsirolimus—Anorexia—Betamethasone—ulcerative colitis	9.22e-05	0.000497	CcSEcCtD
Temsirolimus—Fatigue—Triamcinolone—ulcerative colitis	9.19e-05	0.000496	CcSEcCtD
Temsirolimus—Fatigue—Methylprednisolone—ulcerative colitis	9.17e-05	0.000494	CcSEcCtD
Temsirolimus—Pain—Triamcinolone—ulcerative colitis	9.12e-05	0.000492	CcSEcCtD
Temsirolimus—Abdominal pain—Hydrocortisone—ulcerative colitis	8.95e-05	0.000483	CcSEcCtD
Temsirolimus—Body temperature increased—Hydrocortisone—ulcerative colitis	8.95e-05	0.000483	CcSEcCtD
Temsirolimus—Convulsion—Prednisone—ulcerative colitis	8.94e-05	0.000482	CcSEcCtD
Temsirolimus—Hypertension—Prednisone—ulcerative colitis	8.91e-05	0.00048	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	8.81e-05	0.000475	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	8.81e-05	0.000475	CcSEcCtD
Temsirolimus—Myalgia—Prednisone—ulcerative colitis	8.79e-05	0.000474	CcSEcCtD
Temsirolimus—Arthralgia—Prednisone—ulcerative colitis	8.79e-05	0.000474	CcSEcCtD
Temsirolimus—Anxiety—Prednisone—ulcerative colitis	8.76e-05	0.000472	CcSEcCtD
Temsirolimus—Insomnia—Betamethasone—ulcerative colitis	8.75e-05	0.000472	CcSEcCtD
Temsirolimus—Insomnia—Dexamethasone—ulcerative colitis	8.75e-05	0.000472	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	8.73e-05	0.000471	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	8.7e-05	0.000469	CcSEcCtD
Temsirolimus—Hypersensitivity—Prednisolone—ulcerative colitis	8.54e-05	0.000461	CcSEcCtD
Temsirolimus—Body temperature increased—Triamcinolone—ulcerative colitis	8.43e-05	0.000454	CcSEcCtD
Temsirolimus—Anaphylactic shock—Prednisone—ulcerative colitis	8.42e-05	0.000454	CcSEcCtD
Temsirolimus—Oedema—Prednisone—ulcerative colitis	8.42e-05	0.000454	CcSEcCtD
Temsirolimus—Abdominal pain—Methylprednisolone—ulcerative colitis	8.41e-05	0.000453	CcSEcCtD
Temsirolimus—Decreased appetite—Betamethasone—ulcerative colitis	8.41e-05	0.000453	CcSEcCtD
Temsirolimus—Decreased appetite—Dexamethasone—ulcerative colitis	8.41e-05	0.000453	CcSEcCtD
Temsirolimus—Infection—Prednisone—ulcerative colitis	8.37e-05	0.000451	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Betamethasone—ulcerative colitis	8.35e-05	0.00045	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	8.35e-05	0.00045	CcSEcCtD
Temsirolimus—Hypersensitivity—Hydrocortisone—ulcerative colitis	8.34e-05	0.00045	CcSEcCtD
Temsirolimus—Fatigue—Betamethasone—ulcerative colitis	8.34e-05	0.00045	CcSEcCtD
Temsirolimus—Fatigue—Dexamethasone—ulcerative colitis	8.34e-05	0.00045	CcSEcCtD
Temsirolimus—Pain—Dexamethasone—ulcerative colitis	8.27e-05	0.000446	CcSEcCtD
Temsirolimus—Pain—Betamethasone—ulcerative colitis	8.27e-05	0.000446	CcSEcCtD
Temsirolimus—Nervous system disorder—Prednisone—ulcerative colitis	8.26e-05	0.000445	CcSEcCtD
Temsirolimus—Skin disorder—Prednisone—ulcerative colitis	8.18e-05	0.000441	CcSEcCtD
Temsirolimus—Asthenia—Hydrocortisone—ulcerative colitis	8.12e-05	0.000438	CcSEcCtD
Temsirolimus—Anorexia—Prednisone—ulcerative colitis	8.03e-05	0.000433	CcSEcCtD
Temsirolimus—Pruritus—Hydrocortisone—ulcerative colitis	8.01e-05	0.000432	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Betamethasone—ulcerative colitis	7.91e-05	0.000426	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Dexamethasone—ulcerative colitis	7.91e-05	0.000426	CcSEcCtD
Temsirolimus—Hypersensitivity—Triamcinolone—ulcerative colitis	7.85e-05	0.000423	CcSEcCtD
Temsirolimus—Hypersensitivity—Methylprednisolone—ulcerative colitis	7.84e-05	0.000423	CcSEcCtD
Temsirolimus—Diarrhoea—Hydrocortisone—ulcerative colitis	7.75e-05	0.000418	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Prednisone—ulcerative colitis	7.67e-05	0.000414	CcSEcCtD
Temsirolimus—Dizziness—Prednisolone—ulcerative colitis	7.67e-05	0.000413	CcSEcCtD
Temsirolimus—Asthenia—Triamcinolone—ulcerative colitis	7.65e-05	0.000412	CcSEcCtD
Temsirolimus—Abdominal pain—Dexamethasone—ulcerative colitis	7.65e-05	0.000412	CcSEcCtD
Temsirolimus—Abdominal pain—Betamethasone—ulcerative colitis	7.65e-05	0.000412	CcSEcCtD
Temsirolimus—Body temperature increased—Dexamethasone—ulcerative colitis	7.65e-05	0.000412	CcSEcCtD
Temsirolimus—Body temperature increased—Betamethasone—ulcerative colitis	7.65e-05	0.000412	CcSEcCtD
Temsirolimus—Asthenia—Methylprednisolone—ulcerative colitis	7.63e-05	0.000411	CcSEcCtD
Temsirolimus—MTOR—Signaling by FGFR—JAK2—ulcerative colitis	7.62e-05	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—JAK2—ulcerative colitis	7.62e-05	0.0011	CbGpPWpGaD
Temsirolimus—Insomnia—Prednisone—ulcerative colitis	7.62e-05	0.000411	CcSEcCtD
Temsirolimus—MTOR—Signaling by ERBB2—JAK2—ulcerative colitis	7.59e-05	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—JAK2—ulcerative colitis	7.55e-05	0.00109	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	7.55e-05	0.00109	CbGpPWpGaD
Temsirolimus—Pruritus—Triamcinolone—ulcerative colitis	7.54e-05	0.000407	CcSEcCtD
Temsirolimus—Pruritus—Methylprednisolone—ulcerative colitis	7.52e-05	0.000406	CcSEcCtD
Temsirolimus—Dizziness—Hydrocortisone—ulcerative colitis	7.49e-05	0.000404	CcSEcCtD
Temsirolimus—MTOR—Innate Immune System—FCGR2A—ulcerative colitis	7.46e-05	0.00108	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—ulcerative colitis	7.34e-05	0.00106	CbGpPWpGaD
Temsirolimus—Decreased appetite—Prednisone—ulcerative colitis	7.32e-05	0.000395	CcSEcCtD
Temsirolimus—Rash—Prednisolone—ulcerative colitis	7.31e-05	0.000394	CcSEcCtD
Temsirolimus—Dermatitis—Prednisolone—ulcerative colitis	7.3e-05	0.000394	CcSEcCtD
Temsirolimus—Diarrhoea—Methylprednisolone—ulcerative colitis	7.28e-05	0.000392	CcSEcCtD
Temsirolimus—Fatigue—Prednisone—ulcerative colitis	7.26e-05	0.000392	CcSEcCtD
Temsirolimus—Headache—Prednisolone—ulcerative colitis	7.26e-05	0.000392	CcSEcCtD
Temsirolimus—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	7.24e-05	0.00105	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—RELA—ulcerative colitis	7.21e-05	0.00104	CbGpPWpGaD
Temsirolimus—Constipation—Prednisone—ulcerative colitis	7.2e-05	0.000388	CcSEcCtD
Temsirolimus—Vomiting—Hydrocortisone—ulcerative colitis	7.2e-05	0.000388	CcSEcCtD
Temsirolimus—Rash—Hydrocortisone—ulcerative colitis	7.14e-05	0.000385	CcSEcCtD
Temsirolimus—Dermatitis—Hydrocortisone—ulcerative colitis	7.13e-05	0.000385	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—CXCR1—ulcerative colitis	7.11e-05	0.00103	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—JAK2—ulcerative colitis	7.1e-05	0.00103	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—JAK2—ulcerative colitis	7.1e-05	0.00103	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—JAK2—ulcerative colitis	7.1e-05	0.00103	CbGpPWpGaD
Temsirolimus—Headache—Hydrocortisone—ulcerative colitis	7.09e-05	0.000382	CcSEcCtD
Temsirolimus—FKBP1A—Disease—MAML2—ulcerative colitis	7.08e-05	0.00103	CbGpPWpGaD
Temsirolimus—Dizziness—Triamcinolone—ulcerative colitis	7.05e-05	0.00038	CcSEcCtD
Temsirolimus—MTOR—Signaling by EGFR—JAK2—ulcerative colitis	7.04e-05	0.00102	CbGpPWpGaD
Temsirolimus—Dizziness—Methylprednisolone—ulcerative colitis	7.03e-05	0.000379	CcSEcCtD
Temsirolimus—MTOR—Signaling by SCF-KIT—MMP9—ulcerative colitis	7.03e-05	0.00102	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—JAK2—ulcerative colitis	6.98e-05	0.00101	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—JAK2—ulcerative colitis	6.95e-05	0.00101	CbGpPWpGaD
Temsirolimus—Asthenia—Dexamethasone—ulcerative colitis	6.94e-05	0.000374	CcSEcCtD
Temsirolimus—Asthenia—Betamethasone—ulcerative colitis	6.94e-05	0.000374	CcSEcCtD
Temsirolimus—MTOR—Disease—SEL1L—ulcerative colitis	6.94e-05	0.001	CbGpPWpGaD
Temsirolimus—Gastrointestinal pain—Prednisone—ulcerative colitis	6.89e-05	0.000371	CcSEcCtD
Temsirolimus—Nausea—Prednisolone—ulcerative colitis	6.89e-05	0.000371	CcSEcCtD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—RELA—ulcerative colitis	6.88e-05	0.000996	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CARD9—ulcerative colitis	6.87e-05	0.000995	CbGpPWpGaD
Temsirolimus—Pruritus—Dexamethasone—ulcerative colitis	6.84e-05	0.000369	CcSEcCtD
Temsirolimus—Pruritus—Betamethasone—ulcerative colitis	6.84e-05	0.000369	CcSEcCtD
Temsirolimus—MTOR—BDNF signaling pathway—NFKB1—ulcerative colitis	6.84e-05	0.000991	CbGpPWpGaD
Temsirolimus—Vomiting—Triamcinolone—ulcerative colitis	6.78e-05	0.000365	CcSEcCtD
Temsirolimus—Vomiting—Methylprednisolone—ulcerative colitis	6.76e-05	0.000365	CcSEcCtD
Temsirolimus—MTOR—Immune System—IL7R—ulcerative colitis	6.74e-05	0.000976	CbGpPWpGaD
Temsirolimus—Nausea—Hydrocortisone—ulcerative colitis	6.72e-05	0.000363	CcSEcCtD
Temsirolimus—Rash—Triamcinolone—ulcerative colitis	6.72e-05	0.000362	CcSEcCtD
Temsirolimus—Dermatitis—Triamcinolone—ulcerative colitis	6.71e-05	0.000362	CcSEcCtD
Temsirolimus—Rash—Methylprednisolone—ulcerative colitis	6.71e-05	0.000362	CcSEcCtD
Temsirolimus—Dermatitis—Methylprednisolone—ulcerative colitis	6.7e-05	0.000361	CcSEcCtD
Temsirolimus—Headache—Triamcinolone—ulcerative colitis	6.68e-05	0.00036	CcSEcCtD
Temsirolimus—Headache—Methylprednisolone—ulcerative colitis	6.66e-05	0.000359	CcSEcCtD
Temsirolimus—Body temperature increased—Prednisone—ulcerative colitis	6.66e-05	0.000359	CcSEcCtD
Temsirolimus—Abdominal pain—Prednisone—ulcerative colitis	6.66e-05	0.000359	CcSEcCtD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	6.66e-05	0.000964	CbGpPWpGaD
Temsirolimus—Diarrhoea—Dexamethasone—ulcerative colitis	6.62e-05	0.000357	CcSEcCtD
Temsirolimus—Diarrhoea—Betamethasone—ulcerative colitis	6.62e-05	0.000357	CcSEcCtD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—NFKB1—ulcerative colitis	6.59e-05	0.000954	CbGpPWpGaD
Temsirolimus—MTOR—IRS-mediated signalling—IL6—ulcerative colitis	6.55e-05	0.000948	CbGpPWpGaD
Temsirolimus—Dizziness—Dexamethasone—ulcerative colitis	6.4e-05	0.000345	CcSEcCtD
Temsirolimus—Dizziness—Betamethasone—ulcerative colitis	6.4e-05	0.000345	CcSEcCtD
Temsirolimus—MTOR—IRS-related events—IL6—ulcerative colitis	6.37e-05	0.000922	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—RELA—ulcerative colitis	6.37e-05	0.000922	CbGpPWpGaD
Temsirolimus—Nausea—Triamcinolone—ulcerative colitis	6.33e-05	0.000341	CcSEcCtD
Temsirolimus—Nausea—Methylprednisolone—ulcerative colitis	6.32e-05	0.000341	CcSEcCtD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—IL6—ulcerative colitis	6.31e-05	0.000914	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—JAK2—ulcerative colitis	6.29e-05	0.000911	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—STAT3—ulcerative colitis	6.25e-05	0.000905	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCL20—ulcerative colitis	6.24e-05	0.000904	CbGpPWpGaD
Temsirolimus—MTOR—Disease—LTF—ulcerative colitis	6.22e-05	0.000901	CbGpPWpGaD
Temsirolimus—Hypersensitivity—Prednisone—ulcerative colitis	6.21e-05	0.000335	CcSEcCtD
Temsirolimus—Vomiting—Betamethasone—ulcerative colitis	6.15e-05	0.000332	CcSEcCtD
Temsirolimus—Vomiting—Dexamethasone—ulcerative colitis	6.15e-05	0.000332	CcSEcCtD
Temsirolimus—MTOR—BDNF signaling pathway—STAT3—ulcerative colitis	6.15e-05	0.00089	CbGpPWpGaD
Temsirolimus—MTOR—Insulin receptor signalling cascade—IL6—ulcerative colitis	6.15e-05	0.00089	CbGpPWpGaD
Temsirolimus—MTOR—IGF1R signaling cascade—IL6—ulcerative colitis	6.15e-05	0.00089	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CALM3—ulcerative colitis	6.1e-05	0.000883	CbGpPWpGaD
Temsirolimus—Rash—Dexamethasone—ulcerative colitis	6.1e-05	0.000329	CcSEcCtD
Temsirolimus—Rash—Betamethasone—ulcerative colitis	6.1e-05	0.000329	CcSEcCtD
Temsirolimus—Dermatitis—Dexamethasone—ulcerative colitis	6.09e-05	0.000329	CcSEcCtD
Temsirolimus—Dermatitis—Betamethasone—ulcerative colitis	6.09e-05	0.000329	CcSEcCtD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—ulcerative colitis	6.08e-05	0.00088	CbGpPWpGaD
Temsirolimus—Headache—Dexamethasone—ulcerative colitis	6.06e-05	0.000327	CcSEcCtD
Temsirolimus—Headache—Betamethasone—ulcerative colitis	6.06e-05	0.000327	CcSEcCtD
Temsirolimus—Asthenia—Prednisone—ulcerative colitis	6.04e-05	0.000326	CcSEcCtD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TP53—ulcerative colitis	6.04e-05	0.000875	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—RIPK2—ulcerative colitis	6.01e-05	0.00087	CbGpPWpGaD
Temsirolimus—Pruritus—Prednisone—ulcerative colitis	5.96e-05	0.000321	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—GNA12—ulcerative colitis	5.87e-05	0.00085	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CALM3—ulcerative colitis	5.86e-05	0.000848	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CALM3—ulcerative colitis	5.83e-05	0.000845	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKB1—ulcerative colitis	5.8e-05	0.00084	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CHP1—ulcerative colitis	5.77e-05	0.000836	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—RIPK2—ulcerative colitis	5.77e-05	0.000836	CbGpPWpGaD
Temsirolimus—Diarrhoea—Prednisone—ulcerative colitis	5.76e-05	0.000311	CcSEcCtD
Temsirolimus—Nausea—Dexamethasone—ulcerative colitis	5.75e-05	0.00031	CcSEcCtD
Temsirolimus—Nausea—Betamethasone—ulcerative colitis	5.75e-05	0.00031	CcSEcCtD
Temsirolimus—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	5.72e-05	0.000829	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CTLA4—ulcerative colitis	5.69e-05	0.000824	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—STAT3—ulcerative colitis	5.62e-05	0.000814	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—STAT3—ulcerative colitis	5.6e-05	0.00081	CbGpPWpGaD
Temsirolimus—Dizziness—Prednisone—ulcerative colitis	5.57e-05	0.0003	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—CXCR2—ulcerative colitis	5.57e-05	0.000806	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IL6—ulcerative colitis	5.53e-05	0.000801	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	5.48e-05	0.000793	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	5.48e-05	0.000793	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—NOD2—ulcerative colitis	5.45e-05	0.000789	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—ulcerative colitis	5.45e-05	0.000789	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD79A—ulcerative colitis	5.43e-05	0.000786	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD14—ulcerative colitis	5.42e-05	0.000784	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—NFKB1—ulcerative colitis	5.37e-05	0.000777	CbGpPWpGaD
Temsirolimus—Vomiting—Prednisone—ulcerative colitis	5.36e-05	0.000289	CcSEcCtD
Temsirolimus—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	5.32e-05	0.00077	CbGpPWpGaD
Temsirolimus—Rash—Prednisone—ulcerative colitis	5.31e-05	0.000286	CcSEcCtD
Temsirolimus—Dermatitis—Prednisone—ulcerative colitis	5.31e-05	0.000286	CcSEcCtD
Temsirolimus—Headache—Prednisone—ulcerative colitis	5.28e-05	0.000285	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—CCR6—ulcerative colitis	5.23e-05	0.000758	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—STAT3—ulcerative colitis	5.21e-05	0.000755	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—IL6—ulcerative colitis	5.14e-05	0.000744	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—IL6—ulcerative colitis	5.11e-05	0.000739	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	5.1e-05	0.000739	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—STAT3—ulcerative colitis	5.1e-05	0.000738	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL2—ulcerative colitis	5.08e-05	0.000736	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—VCAM1—ulcerative colitis	5.02e-05	0.000727	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ITGAL—ulcerative colitis	5.01e-05	0.000726	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-DQA1—ulcerative colitis	5.01e-05	0.000725	CbGpPWpGaD
Temsirolimus—Nausea—Prednisone—ulcerative colitis	5e-05	0.00027	CcSEcCtD
Temsirolimus—MTOR—Cellular responses to stress—RELA—ulcerative colitis	5e-05	0.000723	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—DLD—ulcerative colitis	4.98e-05	0.000721	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MAML2—ulcerative colitis	4.96e-05	0.000718	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SEL1L—ulcerative colitis	4.86e-05	0.000703	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—JAK2—ulcerative colitis	4.84e-05	0.0007	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IRF5—ulcerative colitis	4.76e-05	0.00069	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	4.73e-05	0.000685	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CXCL8—ulcerative colitis	4.71e-05	0.000682	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—RELA—ulcerative colitis	4.69e-05	0.000678	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—STAT3—ulcerative colitis	4.62e-05	0.000668	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PTGER4—ulcerative colitis	4.61e-05	0.000667	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IRF8—ulcerative colitis	4.55e-05	0.000659	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CCR6—ulcerative colitis	4.55e-05	0.000659	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	4.52e-05	0.000654	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SLC11A1—ulcerative colitis	4.43e-05	0.000642	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—ADCY5—ulcerative colitis	4.43e-05	0.000641	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—IL6—ulcerative colitis	4.37e-05	0.000632	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FCGR2A—ulcerative colitis	4.34e-05	0.000629	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—ADCY5—ulcerative colitis	4.23e-05	0.000613	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—GHRL—ulcerative colitis	4.22e-05	0.000611	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—NFKB1—ulcerative colitis	4.21e-05	0.00061	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—IL6—ulcerative colitis	4.18e-05	0.000605	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CHP1—ulcerative colitis	4.17e-05	0.000604	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PTPN2—ulcerative colitis	4.16e-05	0.000603	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—IL6—ulcerative colitis	4.11e-05	0.000595	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CALM3—ulcerative colitis	4.09e-05	0.000591	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—RIPK2—ulcerative colitis	4.02e-05	0.000583	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCR1—ulcerative colitis	4e-05	0.000579	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MAML2—ulcerative colitis	3.98e-05	0.000577	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	3.97e-05	0.000574	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—NFKB1—ulcerative colitis	3.95e-05	0.000572	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—IL6—ulcerative colitis	3.93e-05	0.000569	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—IL6—ulcerative colitis	3.91e-05	0.000566	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—IL6—ulcerative colitis	3.89e-05	0.000563	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CRP—ulcerative colitis	3.87e-05	0.000561	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—IL6—ulcerative colitis	3.87e-05	0.00056	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—STAT3—ulcerative colitis	3.79e-05	0.000548	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TLR4—ulcerative colitis	3.71e-05	0.000538	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TNF—ulcerative colitis	3.7e-05	0.000536	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—ulcerative colitis	3.64e-05	0.000527	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—IL6—ulcerative colitis	3.64e-05	0.000527	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—IL6—ulcerative colitis	3.64e-05	0.000527	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—IL6—ulcerative colitis	3.61e-05	0.000522	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—DLD—ulcerative colitis	3.6e-05	0.000521	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—IL6—ulcerative colitis	3.58e-05	0.000518	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-DRB1—ulcerative colitis	3.56e-05	0.000516	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—IL6—ulcerative colitis	3.56e-05	0.000516	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CALM3—ulcerative colitis	3.55e-05	0.000515	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—STAT3—ulcerative colitis	3.55e-05	0.000514	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL20—ulcerative colitis	3.51e-05	0.000508	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—RIPK2—ulcerative colitis	3.5e-05	0.000507	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ADRB2—ulcerative colitis	3.49e-05	0.000506	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CTLA4—ulcerative colitis	3.45e-05	0.000499	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—ICAM1—ulcerative colitis	3.42e-05	0.000495	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	3.41e-05	0.000494	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GNA12—ulcerative colitis	3.3e-05	0.000478	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD79A—ulcerative colitis	3.29e-05	0.000477	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CALM3—ulcerative colitis	3.28e-05	0.000475	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	3.22e-05	0.000467	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NOD2—ulcerative colitis	3.17e-05	0.000459	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD14—ulcerative colitis	3.16e-05	0.000457	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CHP1—ulcerative colitis	3.15e-05	0.000456	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCR2—ulcerative colitis	3.13e-05	0.000453	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—VCAM1—ulcerative colitis	3.05e-05	0.000441	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DQA1—ulcerative colitis	3.04e-05	0.00044	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CDH1—ulcerative colitis	3.02e-05	0.000438	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CHP1—ulcerative colitis	2.97e-05	0.00043	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ADCY5—ulcerative colitis	2.96e-05	0.000429	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR6—ulcerative colitis	2.94e-05	0.000426	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—TP53—ulcerative colitis	2.89e-05	0.000418	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAML2—ulcerative colitis	2.79e-05	0.000404	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—JAK2—ulcerative colitis	2.76e-05	0.0004	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—DLD—ulcerative colitis	2.72e-05	0.000393	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.71e-05	0.000392	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—RELA—ulcerative colitis	2.67e-05	0.000387	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—IL6—ulcerative colitis	2.64e-05	0.000383	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—JAK2—ulcerative colitis	2.64e-05	0.000382	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD4—ulcerative colitis	2.62e-05	0.000379	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTGER4—ulcerative colitis	2.59e-05	0.000375	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ADCY5—ulcerative colitis	2.58e-05	0.000373	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—RELA—ulcerative colitis	2.57e-05	0.000372	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—DLD—ulcerative colitis	2.56e-05	0.000371	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD4—ulcerative colitis	2.51e-05	0.000364	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CD4—ulcerative colitis	2.5e-05	0.000362	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PTGS2—ulcerative colitis	2.48e-05	0.00036	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—IL6—ulcerative colitis	2.48e-05	0.000359	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS1—ulcerative colitis	2.41e-05	0.000349	CbGpPWpGaD
Temsirolimus—MTOR—Disease—ADCY5—ulcerative colitis	2.38e-05	0.000345	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GHRL—ulcerative colitis	2.37e-05	0.000343	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.35e-05	0.00034	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CALM3—ulcerative colitis	2.3e-05	0.000333	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RIPK2—ulcerative colitis	2.26e-05	0.000328	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CRP—ulcerative colitis	2.26e-05	0.000327	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—NFKB1—ulcerative colitis	2.25e-05	0.000326	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CALM3—ulcerative colitis	2.17e-05	0.000314	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—NFKB1—ulcerative colitis	2.16e-05	0.000313	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TLR4—ulcerative colitis	2.16e-05	0.000313	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DRB1—ulcerative colitis	2.16e-05	0.000313	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ICAM1—ulcerative colitis	2.07e-05	0.0003	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ADRB2—ulcerative colitis	1.96e-05	0.000284	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.96e-05	0.000283	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.94e-05	0.000281	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—STAT3—ulcerative colitis	1.94e-05	0.00028	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—JAK2—ulcerative colitis	1.85e-05	0.000268	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CDH1—ulcerative colitis	1.83e-05	0.000265	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.83e-05	0.000265	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.83e-05	0.000265	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TGFB1—ulcerative colitis	1.8e-05	0.00026	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—RELA—ulcerative colitis	1.79e-05	0.000259	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS1—ulcerative colitis	1.74e-05	0.000252	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ABCB1—ulcerative colitis	1.69e-05	0.000244	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL8—ulcerative colitis	1.69e-05	0.000244	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—DLD—ulcerative colitis	1.67e-05	0.000242	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ADCY5—ulcerative colitis	1.67e-05	0.000241	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL2—ulcerative colitis	1.61e-05	0.000233	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.61e-05	0.000233	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—JAK2—ulcerative colitis	1.61e-05	0.000233	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNG—ulcerative colitis	1.58e-05	0.000228	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ADCY5—ulcerative colitis	1.57e-05	0.000228	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CALM3—ulcerative colitis	1.57e-05	0.000227	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—RELA—ulcerative colitis	1.56e-05	0.000225	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MMP9—ulcerative colitis	1.53e-05	0.000221	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD4—ulcerative colitis	1.52e-05	0.000221	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NFKB1—ulcerative colitis	1.51e-05	0.000218	CbGpPWpGaD
Temsirolimus—MTOR—Disease—JAK2—ulcerative colitis	1.48e-05	0.000215	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—ulcerative colitis	1.41e-05	0.000205	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1B—ulcerative colitis	1.41e-05	0.000204	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD4—ulcerative colitis	1.41e-05	0.000204	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL2—ulcerative colitis	1.4e-05	0.000203	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTGS2—ulcerative colitis	1.4e-05	0.000202	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—STAT3—ulcerative colitis	1.36e-05	0.000196	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—ulcerative colitis	1.35e-05	0.000196	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.31e-05	0.00019	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NFKB1—ulcerative colitis	1.31e-05	0.00019	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFB1—ulcerative colitis	1.26e-05	0.000182	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS1—ulcerative colitis	1.24e-05	0.000179	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.23e-05	0.000178	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ABCB1—ulcerative colitis	1.22e-05	0.000177	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CALM3—ulcerative colitis	1.18e-05	0.000171	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—STAT3—ulcerative colitis	1.18e-05	0.000171	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PPARG—ulcerative colitis	1.17e-05	0.00017	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ADCY5—ulcerative colitis	1.14e-05	0.000165	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CALM3—ulcerative colitis	1.11e-05	0.000161	CbGpPWpGaD
Temsirolimus—MTOR—Disease—STAT3—ulcerative colitis	1.09e-05	0.000158	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ALB—ulcerative colitis	1.06e-05	0.000153	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—JAK2—ulcerative colitis	1.04e-05	0.00015	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TP53—ulcerative colitis	1.03e-05	0.00015	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFB1—ulcerative colitis	1.01e-05	0.000146	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RELA—ulcerative colitis	1.01e-05	0.000146	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL8—ulcerative colitis	9.48e-06	0.000137	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—ulcerative colitis	9.47e-06	0.000137	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS2—ulcerative colitis	9.23e-06	0.000134	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL2—ulcerative colitis	9.06e-06	0.000131	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ABCB1—ulcerative colitis	8.67e-06	0.000126	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ADCY5—ulcerative colitis	8.58e-06	0.000124	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP9—ulcerative colitis	8.58e-06	0.000124	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NFKB1—ulcerative colitis	8.49e-06	0.000123	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPARG—ulcerative colitis	8.48e-06	0.000123	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—ulcerative colitis	8.24e-06	0.000119	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS1—ulcerative colitis	8.09e-06	0.000117	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ADCY5—ulcerative colitis	8.09e-06	0.000117	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—STAT3—ulcerative colitis	7.63e-06	0.00011	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ALB—ulcerative colitis	7.63e-06	0.00011	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—ulcerative colitis	7.61e-06	0.00011	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CALM3—ulcerative colitis	7.29e-06	0.000106	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFB1—ulcerative colitis	7.07e-06	0.000102	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS2—ulcerative colitis	6.67e-06	9.66e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPARG—ulcerative colitis	6.4e-06	9.27e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPARG—ulcerative colitis	6.03e-06	8.73e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TP53—ulcerative colitis	5.82e-06	8.43e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALB—ulcerative colitis	5.75e-06	8.33e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ABCB1—ulcerative colitis	5.67e-06	8.21e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALB—ulcerative colitis	5.42e-06	7.85e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—ulcerative colitis	5.33e-06	7.71e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ADCY5—ulcerative colitis	5.29e-06	7.66e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS2—ulcerative colitis	5.03e-06	7.29e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS2—ulcerative colitis	4.74e-06	6.87e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.94e-06	5.71e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALB—ulcerative colitis	3.55e-06	5.13e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS2—ulcerative colitis	3.1e-06	4.49e-05	CbGpPWpGaD
